The European Drug Addiction Prevention (EU-Dap) trial project took place between 2003-2005. Results indicate a positive shift to prevent the use of alcohol, tobacco and other drugs among European students aged 12-14 years.
Today, the EU-Dap project continues
by offering access to the study trial information, classroom resources for teachers and students, a dissemination guide; for spreading better practices and an evaluation of the dissemination strategy.
The aims of the EU-Dap project:
To develop a
drug use prevention
programme for the European school setting
To evaluate the
effectiveness of this programme
To encourage the use of effective drug use prevention programmes in the European Community and to share of better practicesTo decrease prevalence of smoking, unhealthy drinking and use of other drugs among European youth.
Schools are important for implementing drug use prevention programmes because:
Schools can focus
on prevention of alcohol, tobacco and other drug use
when students are young in order to foster healthy children and adolescents.
The school
setting offers the most systematic and efficient way
to reach young people.
Schools are in a position to supervise school policies that when applied fairly and consistently can support students to abstain from alcohol, tobacco and other drugs.
Phase II of EU-Dap
officially started with a kick-off meeting, held in
Turin, Italy 20-21 October 2006. The steering committee discussed strategies to:
Revise the EU-Dap program “Unplugged”.
Introduce the EU-Dap
programme to new countries.
Disseminate effective prevention programmes.
-
Conduct a field study to evaluate the
effectiveness of the dissemination
strategies.
Read more about
phase II
The phase I countries that will
continue to phase II are: Austria, Belgium, Greece,
Italy, Spain and Sweden. Poland and the Czech Republic
have joined the EU-Dap steering committee to implement
the programme as new participating
countries.
EU-Dap was granted by the European
Commission within the 2002 and 2005 Public Health
Programme for drug prevention (Grant #SPC 2002376 and
Grant #SPC 2005312).
